Growth Metrics

Disc Medicine (IRON) Change in Accured Expenses (2020 - 2026)

Disc Medicine (IRON) reported Change in Accured Expenses of -$8.7 million for Q1 2026, down 136.76% year-over-year from $23.8 million in Q1 2025, and down 296.45% on a QoQ basis from $4.4 million in Q4 2025.

Disc Medicine (IRON) has 7 years of Change in Accured Expenses data on file, last reported at -$8.7 million in Q1 2026.

  • Quarterly Change in Accured Expenses fell 136.76% year-over-year to -$8.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 69.46% YoY) and the FY2025 annual result came in at $6.9 million, up 309.4% from the prior year.
  • Change in Accured Expenses eased to -$8.7 million in Q1 2026 per IRON's latest filing, from $4.4 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $5.0 million in Q3 2025 and bottomed at -$8.7 million in Q1 2026.
  • The 5-year median for Change in Accured Expenses is $942000.0 (2023), against an average of $186470.6.
  • The widest annual swing landed in 2022, when Change in Accured Expenses jumped 3824.53%; it then slumped 11477.78% in 2023.
  • Tracing IRON's Change in Accured Expenses over 5 years: stood at $2.0 million in 2022, then jumped by 36.17% to $2.7 million in 2023, then decreased by 13.39% to $2.3 million in 2024, then jumped by 90.98% to $4.4 million in 2025, then slumped by 296.45% to -$8.7 million in 2026.
  • Per Business Quant, the three latest IRON Change in Accured Expenses figures stand at -$8.7 million (Q1 2026), $4.4 million (Q4 2025), and $5.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 931,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 70.50 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 107.70 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -176.03 Mn
10 Disc Medicine 2.76 Bn 2.03 Bn - -8.73 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -8.73 Mn
Mar 31, 2026 -8.73 Mn
Dec 31, 2025 4.45 Mn
Dec 31, 2025 4.45 Mn
Sep 30, 2025 4.95 Mn
Sep 30, 2025 4.95 Mn
Jun 30, 2025 1.17 Mn
Jun 30, 2025 1.17 Mn
Mar 31, 2025 -3.69 Mn
Mar 31, 2025 -3.69 Mn
Dec 31, 2024 2.33 Mn
Dec 31, 2024 2.33 Mn
Sep 30, 2024 1.48 Mn
Sep 30, 2024 1.48 Mn
Jun 30, 2024 962,000.00
Jun 30, 2024 962,000.00
Mar 31, 2024 -3.09 Mn
Mar 31, 2024 -3.09 Mn
Dec 31, 2023 2.69 Mn
Dec 31, 2023 2.69 Mn
Sep 30, 2023 942,000.00
Sep 30, 2023 942,000.00
Jun 30, 2023 293,000.00
Jun 30, 2023 293,000.00
Mar 31, 2023 -2.08 Mn
Mar 31, 2023 -2.08 Mn
Dec 31, 2022 1.97 Mn
Dec 31, 2022 1.97 Mn
Sep 30, 2022 448,000.00
Sep 30, 2022 448,000.00
Jun 30, 2022 -902,000.00
Jun 30, 2022 -902,000.00
Mar 31, 2022 -18,000.00
Mar 31, 2022 -18,000.00
Dec 31, 2021 -53,000.00
Dec 31, 2021 -53,000.00
Sep 30, 2021 1.71 Mn
Sep 30, 2021 1.71 Mn
Jun 30, 2021 238,000.00
Jun 30, 2021 238,000.00
Mar 31, 2021 -348,000.00
Mar 31, 2021 -348,000.00
Dec 31, 2020 422,588.00
Dec 31, 2020 422,588.00
Sep 30, 2020 391,999.00
Sep 30, 2020 391,999.00
Jun 30, 2020 674,000.00
Jun 30, 2020 674,000.00
Mar 31, 2020 -1.23 Mn
Mar 31, 2020 -1.23 Mn